View in EDS HTML Full Text PDF Full Text

ROS1 immunohistochemistry as a potential predictive biomarker for ROS1‐targeted therapy in breast cancer: impact of antibody clone selection.

Saved in:
Bibliographic Details
Title: ROS1 immunohistochemistry as a potential predictive biomarker for ROS1‐targeted therapy in breast cancer: impact of antibody clone selection.
Authors: Sokolova, Anna1,2 (AUTHOR), Joshi, Vaibhavi1 (AUTHOR), Chittoory, Haarika1 (AUTHOR), Walsh, Michael2 (AUTHOR), Lim, Malcolm1 (AUTHOR), Kutasovic, Jamie R1 (AUTHOR), Ferguson, Kaltin3 (AUTHOR), Simpson, Peter T1,4 (AUTHOR), Lakhani, Sunil R1,5 (AUTHOR), McCart Reed, Amy E1 (AUTHOR) amy.reed@uq.edu.au
Source: Histopathology. Aug2025, Vol. 87 Issue 2, p223-234. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:03090167
DOI:10.1111/his.15465